Maggie C.U. Cheang

33.9k citations

122 papers · 21.3k indexed · 9 hit papers · h-index 47

Oncology top 0.05%
Cancer Research top 0.02%
Molecular Biology top 0.5%
Pulmonary and Respiratory Medicine top 0.5%
Pathology and Forensic Medicine top 0.1%

Co-authors: Torsten O. Nielsen Charles M. Perou David Voduc Samuel Leung Hagen F. Kennecke Philip S. Bernard Joel S. Parker Stephen Chia
Topics: Breast Cancer Treatment Studies (60 papers)HER2/EGFR in Cancer Research (51 papers)Advanced Breast Cancer Therapies (20 papers)
Cited by: Cancer Research Oncology Pathology and Forensic Medicine
Journals: JAMA Nature Communications Journal of Clinical Oncology
Partner nations: United States Canada United Kingdom

In The Last Decade

Maggie C.U. Cheang

118 papers receiving 20.9k citations

Hit Papers

5 papers align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Supervised Risk Predictor of Breast Cancer Based on Intrinsic Subtypes

2009 3.1k citations Joel S. Parker, Michael E. Mullins et al. Journal of Clinical Oncology profile →
Race, Breast Cancer Subtypes, and Survival in the Carolina Breast Cancer Study

2006 3.0k citations Lisa A. Carey, Charles M. Perou et al. profile →
Immunohistochemical and Clinical Characterization of the Basal-Like Subtype of Invasive Breast Carcinoma

2004 2.1k citations Torsten O. Nielsen, Maggie C.U. Cheang et al. Clinical Cancer Research profile →
Ki67 Index, HER2 Status, and Prognosis of Patients With Luminal B Breast Cancer

2009 1.6k citations Maggie C.U. Cheang, Stephen Chia et al. JNCI Journal of the National Cancer Institute profile →
Metastatic Behavior of Breast Cancer Subtypes

2010 1.6k citations Hagen F. Kennecke, Maggie C.U. Cheang et al. Journal of Clinical Oncology profile →
Breast Cancer Subtypes and the Risk of Local and Regional Relapse

2010 960 citations K. David Voduc, Maggie C.U. Cheang et al. Journal of Clinical Oncology profile →
Basal-Like Breast Cancer Defined by Five Biomarkers Has Superior Prognostic Value than Triple-Negative Phenotype

2008 945 citations Maggie C.U. Cheang, David Voduc et al. Clinical Cancer Research profile →
Mutation tracking in circulating tumor DNA predicts relapse in early breast cancer

2015 814 citations Maggie C.U. Cheang, Mitch Dowsett et al. profile →
A Comparison of PAM50 Intrinsic Subtyping with Immunohistochemistry and Clinical Prognostic Factors in Tamoxifen-Treated Estrogen Receptor–Positive Breast Cancer

2010 542 citations Torsten O. Nielsen, Joel S. Parker et al. Clinical Cancer Research profile →

Peers

Countries citing papers authored by Maggie C.U. Cheang

Since Specialization

Citations

This map shows the geographic impact of Maggie C.U. Cheang's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Maggie C.U. Cheang with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Maggie C.U. Cheang more than expected).

Fields of papers citing papers by Maggie C.U. Cheang

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Maggie C.U. Cheang. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Maggie C.U. Cheang. The network helps show where Maggie C.U. Cheang may publish in the future.

Co-authorship network of co-authors of Maggie C.U. Cheang

This figure shows the co-authorship network connecting the top 25 collaborators of Maggie C.U. Cheang. A scholar is included among the top collaborators of Maggie C.U. Cheang based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Maggie C.U. Cheang. Maggie C.U. Cheang is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	Integrated Multimodal Analyses of DNA Damage Response and Immune Markers as Predictors of Response in Metastatic Triple-Negative Breast Cancer in the TNT Trial (NCT00532727) 2023 ·Clinical Cancer Research ·Holly Tovey,(unknown),Joel S. Parker,Katherine A. Hoadley,Jelmar Quist,Sarah Kernaghan,Lucy Kilburn,Roberto Salgado,Sherene Loi,Richard D. Kennedy,Ioannis Roxanis,Patrycja Gazińska,Sarah E. Pinder,Judith M. Bliss,Charles M. Perou,Syed Haider,Anita Grigoriadis,Andrew Tutt,Maggie C.U. Cheang	3
2	Development and validation for research assessment of Oncotype DX® Breast Recurrence Score, EndoPredict® and Prosigna® 2021 ·npj Breast Cancer ·Richard Buus,Zsolt Szíjgyártó,Eugene F. Schuster,Hui Xiao,Ben P. Haynes,Ivana Šestak,Jack Cuzick,Laia Paré,Elia Seguí,Núria Chic,Aleix Prat,Mitch Dowsett,Maggie C.U. Cheang	9
3	Long-term outcome and prognostic value of Ki67 after perioperative endocrine therapy in postmenopausal women with hormone-sensitive early breast cancer (POETIC): an open-label, multicentre, parallel-group, randomised, phase 3 trial 2020 ·The Lancet Oncology ·Ian Smith,J.F.R. Robertson,Lucy Kilburn,Maggie Wilcox,Abigail Evans,Chris Holcombe,Kieran Horgan,Cliona Kirwan,Elizabeth Mallon,Mark Sibbering,Anthony Skene,Raghavan Vidya,Maggie C.U. Cheang,Jane Banerji,James P. Morden,Kally Sidhu,Andrew Dodson,Judith M. Bliss,Mitch Dowsett	147
4	Early Enrichment of ESR1 Mutations and the Impact on Gene Expression in Presurgical Primary Breast Cancer Treated with Aromatase Inhibitors 2019 ·Clinical Cancer Research ·Mariana Ferreira Leal,Ben P. Haynes,Eugene F. Schuster,Belinda Yeo,Maria Afentakis,Lila Zabaglo,Vera Martins,Richard Buus,Andrew Dodson,Maggie C.U. Cheang,Ian E. Smith,Lesley‐Ann Martin,Mitch Dowsett	13
5	Impact of aromatase inhibitor treatment on global gene expression and its association with antiproliferative response in ER+ breast cancer in postmenopausal patients 2019 ·Breast Cancer Research ·(unknown),Qiong Gao,(unknown),Maggie C.U. Cheang,James P. Morden,Ricardo Ribas,Kally Sidhu,David M. Evans,Vera Martins,Andrew Dodson,Anthony Skene,Chris Holcombe,Elizabeth Mallon,Abigail Evans,Judith M. Bliss,J.F.R. Robertson,Ian Smith,Lesley‐Ann Martin,Mitch Dowsett	16
6	A Four-gene Decision Tree Signature Classification of Triple-negative Breast Cancer: Implications for Targeted Therapeutics 2018 ·Molecular Cancer Therapeutics ·Jelmar Quist,Hasan Mirza,Maggie C.U. Cheang,Melinda L. Telli,Joyce O’Shaughnessy,Christopher J. Lord,Andrew Tutt,Anita Grigoriadis	20
7	Genomic markers of panitumumab resistance including ERBB2/HER2 in a phase II study of KRAS wild-type (wt) metastatic colorectal cancer (mCRC) 2016 ·Oncotarget ·Garrett Barry,Maggie C.U. Cheang,(unknown),Hagen F. Kennecke	10
8	Response and survival of breast cancer intrinsic subtypes following multi-agent neoadjuvant chemotherapy 2015 ·BMC Medicine ·Aleix Prat,Huihui Fan,Aranzazu Fernández-Martínez,Katherine A. Hoadley,Rossella Martinello,María Vidal,Margarita Viladot,Estela Pineda,Ana Arance,Montserrat Muñoz-Mateu,Laia Paré,Maggie C.U. Cheang,Bárbara Adamo,Charles M. Perou	112
9	Molecular Heterogeneity and Response to Neoadjuvant Human Epidermal Growth Factor Receptor 2 Targeting in CALGB 40601, a Randomized Phase III Trial of Paclitaxel Plus Trastuzumab With or Without Lapatinib 2015 ·Journal of Clinical Oncology ·Lisa A. Carey,Donald A. Berry,Constance Cirrincione,William T. Barry,Brandelyn N. Pitcher,Lyndsay N. Harris,David W. Ollila,Ian E. Krop,N. Lynn Henry,Douglas Weckstein,Carey K. Anders,Baljit Singh,Katherine A. Hoadley,Michael D. Iglesia,Maggie C.U. Cheang,Charles M. Perou,Eric P. Winer,Clifford A. Hudis	263
10	αB-crystallin expression in breast cancer is associated with brain metastasis 2015 ·npj Breast Cancer ·K. David Voduc,Torsten O. Nielsen,Charles M. Perou,J. Chuck Harrell,Cheng Fan,Hagen F. Kennecke,Andy J. Minn,Vincent L. Cryns,Maggie C.U. Cheang	28
11	Predicting Drug Responsiveness in Human Cancers Using Genetically Engineered Mice 2013 ·Clinical Cancer Research ·Jerry Usary,Wei Zhao,David B. Darr,Patrick J. Roberts,Mei Liu,(unknown),Olga Karginova,(unknown),Austin J. Combest,Arlene S. Bridges,Aleix Prat,Maggie C.U. Cheang,Jason I. Herschkowitz,Jeffrey M. Rosen,William C. Zamboni,Norman E. Sharpless,Charles M. Perou	40
12	Molecular Characterization of Basal-Like and Non-Basal-Like Triple-Negative Breast Cancer 2013 ·The Oncologist ·Aleix Prat,Bárbara Adamo,Maggie C.U. Cheang,Carey K. Anders,Lisa A. Carey,Charles M. Perou	403
13	Responsiveness of Intrinsic Subtypes to Adjuvant Anthracycline Substitution in the NCIC.CTG MA.5 Randomized Trial 2012 ·Clinical Cancer Research ·Maggie C.U. Cheang,K. David Voduc,Dongsheng Tu,Shan Jiang,Samuel Leung,Stephen Chia,Lois E. Shepherd,Mark N. Levine,Kathleen I. Pritchard,Sherri R. Davies,Inge J. Stijleman,Carole Davis,Mark Ebbert,Joel S. Parker,Matthew J. Ellis,Philip S. Bernard,Charles M. Perou,Torsten O. Nielsen	105
14	Assessment of Topoisomerase II α Status in Breast Cancer by Quantitative PCR, Gene Expression Microarrays, Immunohistochemistry, and Fluorescence in Situ Hybridization 2011 ·American Journal Of Pathology ·Atocha Romero,Miguel Martín,Maggie C.U. Cheang,José Antonio López García‐Asenjo,Belén Oliva,Xiaping He,Miguel de la Hoya,José Á. García-Sáenz,(unknown),Eduardo Díaz‐Rubio,Charles M. Perou,(unknown)	57
15	A Comparison of PAM50 Intrinsic Subtyping with Immunohistochemistry and Clinical Prognostic Factors in Tamoxifen-Treated Estrogen Receptor–Positive Breast Cancerbreakdown → 2010 ·Clinical Cancer Research ·Torsten O. Nielsen,Joel S. Parker,Samuel Leung,D. Voduc,Mark Ebbert,Tammi L. Vickery,Sherri R. Davies,Jacqueline Snider,Inge J. Stijleman,Jerry P. Reed,Maggie C.U. Cheang,Elaine R. Mardis,Charles M. Perou,Philip S. Bernard,Matthew J. Ellis	542
16	Breast Cancer Subtypes and Response to Docetaxel in Node-Positive Breast Cancer: Use of an Immunohistochemical Definition in the BCIRG 001 Trial 2009 ·Journal of Clinical Oncology ·Judith Hugh,John Hanson,Maggie C.U. Cheang,Torsten O. Nielsen,Charles M. Perou,Charles Dumontet,John C. Reed,Maryla Krajewska,Isabelle Treilleux,Matthieu Rupin,E. Magherini,John R. Mackey,Miguel Martín,Charles L. Vogel	407
17	Supervised Risk Predictor of Breast Cancer Based on Intrinsic Subtypesbreakdown → 2009 ·Journal of Clinical Oncology ·Joel S. Parker,Michael E. Mullins,Maggie C.U. Cheang,Samuel Leung,David Voduc,Tammi L. Vickery,Sherri R. Davies,(unknown),Xiaping He,Zhiyuan Hu,John F. Quackenbush,Inge J. Stijleman,Juan Palazzo,J. S. Marron,Andrew B. Nobel,Elaine R. Mardis,Torsten O. Nielsen,Matthew J. Ellis,Charles M. Perou,Philip S. Bernard	3093
18	Ki67 Index, HER2 Status, and Prognosis of Patients With Luminal B Breast Cancerbreakdown → 2009 ·JNCI Journal of the National Cancer Institute ·Maggie C.U. Cheang,Stephen Chia,David Voduc,Dongxia Gao,Samuel Leung,Jacqueline Snider,Mark Watson,Sherri R. Davies,Philip S. Bernard,Joel S. Parker,Charles M. Perou,Matthew J. Ellis,Torsten O. Nielsen	1641
19	Disruption of the Y-Box Binding Protein-1 Results in Suppression of the Epidermal Growth Factor Receptor and HER-2 2006 ·Cancer Research ·Joyce C. Wu,Cathy Lee,Daniel Yokom,Helen Jiang,Maggie C.U. Cheang,Erika Yorida,Dmitry Turbin,Isabelle M. Berquin,Peter R. Mertens,Thomas Iftner,C. Blake Gilks,Sandra E. Dunn	136
20	Akt phosphorylates the Y-box binding protein 1 at Ser102 located in the cold shock domain and affects the anchorage-independent growth of breast cancer cells 2005 ·Oncogene ·Brent W. Sutherland,Jill E. Kucab,Joyce C. Wu,Cathy Lee,Maggie C.U. Cheang,Erika Yorida,Dmitry Turbin,Shoukat Dedhar,Colleen C. Nelson,Michaël Pollak,H. Leighton Grimes,Kathy D. Miller,Sunil Badve,David G. Huntsman,(unknown),Min Chen,Catherine J. Pallen,Sandra E. Dunn	249

About Maggie C.U. Cheang

Maggie C.U. Cheang is a scholar working on Cancer Research, Oncology and Pulmonary and Respiratory Medicine, having authored 122 papers that have together received 21.3k indexed citations. Recurring topics across this work include Breast Cancer Treatment Studies (60 papers), HER2/EGFR in Cancer Research (51 papers) and Advanced Breast Cancer Therapies (20 papers). The work is most often cited by research in Cancer Research (12.4k citations), Oncology (12.6k citations) and Pathology and Forensic Medicine (3.4k citations). Maggie C.U. Cheang has collaborated with scholars based in United States, Canada and United Kingdom. Frequent co-authors include Torsten O. Nielsen, Charles M. Perou, David Voduc, Samuel Leung, Hagen F. Kennecke, Philip S. Bernard, Joel S. Parker, Stephen Chia, Matthew J. Ellis and Karen A. Gelmon. Their work appears in journals such as JAMA, Nature Communications and Journal of Clinical Oncology.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact